John Schreurs

Years Active: 2023-2023
Publications (10 Years): 1

This page only lists publications with an associated author ORCID identifier.

Publications

Lina Van Der Straten, Claudia A M Stege, Sabina Kersting, Kazem Nasserinejad, Julie Dubois, Johan A Dobber, Clemens H M Mellink, Anne-Marie F van der Kevie-Kersemaekers, Ludo M Evers, Fransien de Boer, Harry R Koene, John Schreurs, Marjolein van der Klift, Gerjo A Velders, Ellen van der Spek, Hanna M van der Straaten, Mels Hoogendoorn, Michel Van Gelder, Eduardus F M Posthuma, Hein P J Visser, Ilse Houtenbos, Cecile A M Idink, Djamila E Issa, Ellen C Dompeling, Henk C T van Zaanen, Hendrik Veelken, Henriette Levenga, Lidwine W Tick, Wim E Terpstra, Sanne H Tonino, Peter E Westerweel, Anton W Langerak, Arnon P Kater, Mark-David Levin
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit CLL patients. Blood (2023)

John Schreurs.css-eqlu8i{font-size:small;padding-left:4px;}